Insider Transactions Reported by 24 Insiders of 180 Life Sciences Corp.

Symbol
ATNF, ATNFW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Palo Alto, CA

Insiders trading volume in the past year

180 Life Sciences Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Elray Resources, Inc. Former 10% Owner $4.18M -$9.28M -68.9% Jul 27, 2025
Blair Jordan Chief Executive Officer, Director $1.58M Aug 21, 2025
McAndrew Rudisill Chief Executive Officer, Director $956K Nov 12, 2025
Ryan Smith Director $296K Dec 1, 2025
Stephen H. Shoemaker Director $292K Aug 8, 2025
Steinman Lawrence Director $234K Jul 12, 2025
John Saunders Chief Financial Officer $144K Nov 15, 2025
Jason New Director $95.1K Nov 12, 2025
Marc Feldmann Director $47.2K Dec 28, 2023
Eric Van Lent Chief Accounting Officer $34.8K Jul 12, 2025
James N. Woody Chief Executive Officer, Director $12.6K Dec 15, 2023
Jay Goodman Director $12.2K Feb 20, 2025
Donald A. McGovern Jr. Director $10.4K Sep 4, 2023
Pamela Marrone Director $6.55K Sep 4, 2023
Jonathan B. Rothbard Chief Scientific Officer $5.27K Sep 4, 2023
Lawrence Marshall Gold Director $4.65K Sep 4, 2023
Russell T. Ray Director $4.59K Sep 4, 2023
Quan Vu COO / Chief Business Officer $3.85K Dec 16, 2021
Ozan Pamir Cfo $1.69K Sep 4, 2023
Teresa DeLuca Director $95.00 Sep 4, 2023
Andrew Suckling Director $0 Nov 12, 2025
Crystal Heter Director $0 Nov 12, 2025
Francis Knuettel II Director Sep 4, 2023
Omar Jimenez Director Mar 7, 2024

Recent Insider Transactions by Companies or Individuals for 180 Life Sciences Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.